Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |